Article
The epilepsy phenome/genome project.
Clinical trials (London, England) - 1 Aug 2013
Abou-Khalil Bassel, Alldredge Brian, Bautista Jocelyn, Berkovic Sam, Bluvstein Judith, Boro Alex, Cascino Gregory, Consalvo Damian, Cristofaro Sabrina, Crumrine Patricia, Devinsky Orrin, Dlugos Dennis, Epstein Michael, Fahlstrom Robyn, Fiol Miguel, Fountain Nathan, Fox Kristen, French Jacqueline, Freyer Karn Catharine, Friedman Daniel, Geller Eric, Glauser Tracy, Glynn Simon, Haas Kevin, Haut Sheryl, Hayward Jean, Helmers Sandra, Joshi Sucheta, Kanner Andres, Kirsch Heidi, Knowlton Robert, Kossoff Eric, Kuperman Rachel, Kuzniecky Ruben, Lowenstein Daniel, McGuire Shannon, Motika Paul, Nesbitt Gerard, Novotny Edward, Ottman Ruth, Paolicchi Juliann, Parent Jack, Park Kristen, Poduri Annapurna, Risch Neil, Sadleir Lynette, Scheffer Ingrid, Shellhaas Renee, Sherr Elliott, Shih Jerry J, Shinnar Shlomo, Singh Rani, Sirven Joseph, Smith Michael, Sullivan Joe, Thio Liu Lin, Venkat Anu, Vining Eileen, von Allmen Gretchen, Weisenberg Judith, Widdess-Walsh Peter, Winawer Melodie
Abstract excerpt
BACKGROUND: Epilepsy is a common neurological disorder that affects approximately 50 million people worldwide. Both risk of epilepsy and response to treatment partly depend on genetic factors, and gene identification is a promising approach to target new prediction, treatment, and prevention strategies. However, despite significant progress in the identification of genes causing epilepsy in families with a...
Read the complete abstract on PubMed